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price out of their own pocket in order to obtain treatment
with Epoetin- rather than undergo ABD. One of six
prices was randomly assigned to each participant ($100,
500, 1000, 1500, 2000, 2500). Internal consistency was
examined by correlating willingness to pay (WTP) values
with risk perceptions and patient characteristics.
RESULTS: Mean WTP for Epoetin- was $1845 in the
Epoetin- group and $1309 per patient in the ABD
group. In multivariate analysis, WTP varied with fear of
transfusion and education level, as expected. The proba-
bility of purchasing Epoetin- continuously decreased
with price in 10 of 12 observations. 
CONCLUSIONS: Our findings indicate high internal con-
sistency of the survey. Patients indicated considerable WTP
for Epoetin- to reduce the risk of allogeneic transfusion
relative to ABD. As indicated by the higher willingness to
pay in the Epoetin- group, patients may perceive autolo-
gous blood donation to be more inconvenient than they
rate it once they have experienced the procedure.
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OBJECTIVES: A US multicenter study of Epoetin- ver-
sus pre-operative autologous donation (PAD) in patients
undergoing major orthopedic surgery showed that Epoe-
tin- reduced the risk of allogeneic transfusion. In addi-
tion, patients receiving Epoetin- had higher postopera-
tive hemoglobin levels than PAD patients. We examined
1) whether higher postoperative hemoglobin levels are as-
sociated with a reduced postoperative length of stay; and
2) the relationship between treatment assignment and
postoperative stay.
METHODS: Analyses were stratified by type of surgery
(hip or knee). Multivariate analysis was used to explore
the relationship between postoperative hemoglobin levels
and postoperative length of stay. The relation between
treatment assignment and postoperative stay was exam-
ined using both univariate and multivariate analysis.
RESULTS: We found a relationship between postopera-
tive hemoglobin levels and postoperative length of stay in
the patients undergoing knee replacement, but not among
hip patients. In the univariate analysis, there was no dif-
ference in postoperative stay between the Epoetin- group
and the PAD group among hip patients 4.91 (2.07 days)
versus 4.90 (2.66 days). Among knee patients, the post-
operative length of stay in the Epoetin- group was 4.27
(1.60 days, significantly lower than in the PAD group,
4.70 (1.80 days [p  .044]). Multivariate analysis con-
firmed these findings. 
CONCLUSIONS: In addition to reducing the exposure to
allogeneic blood, Epoetin- significantly reduced post-
operative length of stay when compared to pre-operative
autologous donation among patients undergoing knee re-
placement surgery. The absence of a similar effect among
patients undergoing hip replacement may be explained by
the finding that postoperative hemoglobin level is not a
predictor of postoperative length of stay among these pa-
tients.
